Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete for Contact Lens Discomfort
NCT03848221Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2019
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
A Phase 4 trial of propylene glycol-hydroxypropyl guar nanoemulsion in Contact lens discomfort (CLD), dry eye disease (DED), sponsored by University of Alabama at Birmingham. Started May 2019; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
Contact lens discomfort (CLD)dry eye disease (DED)
Beyond the preview
Go deeper on NCT03848221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03848221.